Ligand Pharmaceuticals Statistics
Total Valuation
LGND has a market cap or net worth of $3.85 billion. The enterprise value is $3.64 billion.
| Market Cap | 3.85B |
| Enterprise Value | 3.64B |
Important Dates
The last earnings date was Thursday, November 6, 2025, before market open.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LGND has 19.68 million shares outstanding. The number of shares has increased by 6.20% in one year.
| Current Share Class | 19.68M |
| Shares Outstanding | 19.68M |
| Shares Change (YoY) | +6.20% |
| Shares Change (QoQ) | +3.53% |
| Owned by Insiders (%) | 2.12% |
| Owned by Institutions (%) | 107.23% |
| Float | 19.26M |
Valuation Ratios
The trailing PE ratio is 78.64 and the forward PE ratio is 36.45. LGND's PEG ratio is 2.43.
| PE Ratio | 78.64 |
| Forward PE | 36.45 |
| PS Ratio | 15.02 |
| Forward PS | 15.07 |
| PB Ratio | 4.05 |
| P/TBV Ratio | 6.27 |
| P/FCF Ratio | 125.30 |
| P/OCF Ratio | 120.77 |
| PEG Ratio | 2.43 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 57.76, with an EV/FCF ratio of 118.36.
| EV / Earnings | 74.94 |
| EV / Sales | 14.49 |
| EV / EBITDA | 57.76 |
| EV / EBIT | 126.21 |
| EV / FCF | 118.36 |
Financial Position
The company has a current ratio of 24.69, with a Debt / Equity ratio of 0.47.
| Current Ratio | 24.69 |
| Quick Ratio | 23.66 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | 7.02 |
| Debt / FCF | 14.66 |
| Interest Coverage | 7.57 |
Financial Efficiency
Return on equity (ROE) is 5.42% and return on invested capital (ROIC) is 1.60%.
| Return on Equity (ROE) | 5.42% |
| Return on Assets (ROA) | 1.48% |
| Return on Invested Capital (ROIC) | 1.60% |
| Return on Capital Employed (ROCE) | 1.99% |
| Revenue Per Employee | $3.69M |
| Profits Per Employee | $714,426 |
| Employee Count | 68 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 6.74 |
Taxes
In the past 12 months, LGND has paid $14.40 million in taxes.
| Income Tax | 14.40M |
| Effective Tax Rate | 22.86% |
Stock Price Statistics
The stock price has increased by +72.72% in the last 52 weeks. The beta is 0.86, so LGND's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | +72.72% |
| 50-Day Moving Average | 194.56 |
| 200-Day Moving Average | 146.35 |
| Relative Strength Index (RSI) | 52.13 |
| Average Volume (20 Days) | 213,824 |
Short Selling Information
The latest short interest is 1.10 million, so 5.57% of the outstanding shares have been sold short.
| Short Interest | 1.10M |
| Short Previous Month | 1.11M |
| Short % of Shares Out | 5.57% |
| Short % of Float | 5.69% |
| Short Ratio (days to cover) | 4.72 |
Income Statement
In the last 12 months, LGND had revenue of $251.23 million and earned $48.58 million in profits. Earnings per share was $2.49.
| Revenue | 251.23M |
| Gross Profit | 154.74M |
| Operating Income | 28.85M |
| Pretax Income | 62.98M |
| Net Income | 48.58M |
| EBITDA | 63.03M |
| EBIT | 28.85M |
| Earnings Per Share (EPS) | $2.49 |
Balance Sheet
The company has $664.52 million in cash and $451.00 million in debt, giving a net cash position of $213.53 million or $10.85 per share.
| Cash & Cash Equivalents | 664.52M |
| Total Debt | 451.00M |
| Net Cash | 213.53M |
| Net Cash Per Share | $10.85 |
| Equity (Book Value) | 950.17M |
| Book Value Per Share | 48.34 |
| Working Capital | 723.38M |
Cash Flow
In the last 12 months, operating cash flow was $31.92 million and capital expenditures -$1.16 million, giving a free cash flow of $30.76 million.
| Operating Cash Flow | 31.92M |
| Capital Expenditures | -1.16M |
| Free Cash Flow | 30.76M |
| FCF Per Share | $1.56 |
Margins
Gross margin is 61.59%, with operating and profit margins of 11.48% and 19.34%.
| Gross Margin | 61.59% |
| Operating Margin | 11.48% |
| Pretax Margin | 25.07% |
| Profit Margin | 19.34% |
| EBITDA Margin | 25.09% |
| EBIT Margin | 11.48% |
| FCF Margin | 12.24% |
Dividends & Yields
LGND does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.20% |
| Shareholder Yield | -6.20% |
| Earnings Yield | 1.26% |
| FCF Yield | 0.80% |
Analyst Forecast
The average price target for LGND is $239.33, which is 22.21% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $239.33 |
| Price Target Difference | 22.21% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 22.21% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 19, 2010. It was a reverse split with a ratio of 1:6.
| Last Split Date | Nov 19, 2010 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
LGND has an Altman Z-Score of 4 and a Piotroski F-Score of 5.
| Altman Z-Score | 4 |
| Piotroski F-Score | 5 |